| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Camp4 Therapeutics Corporation's insiders have reduced their positions by a net 583,613 shares worth roughly $2.5M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.03M | $7.79M | - | |
| CEO | 285.0K | $1.09M | - | |
| Dir | 186.4K | $713.9K | - | |
| Other | 12.6K | $48.3K | - | |
| CFO | 10.0K | $38.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Amir Nashat49 | Director, 10% Owner | Buy | 909,090 | $11.00 | $9,999,990.00 | New | -63.3% | -68.0% | |
| Oct 15, 2024 | Andrew J. Schwab61 | Director, 10% Owner | Buy | 909,090 | $11.00 | $9,999,990.00 | +53.0% | -63.3% | -68.0% | |
| Oct 15, 2024 | Polaris Management Co. VII, L.l.c. | 10% Owner | Buy | 909,090 | $11.00 | $9,999,990.00 | New | -63.3% | -68.0% |